You searched for - Page 56 of 145 - KFF Health News

Listen: Device Is Said To Ease Opioid Withdrawal, But Does The Evidence Support It?

By Jake Harper, Side Effects Public Media May 4, 2018 KFF Health News Original

A device called the Bridge is supposed to mitigate the misery of withdrawal sickness, but scientific evidence doesn’t yet show that it works.

One Twin’s Difficult Birth Puts A Project Designed To Reduce C-Sections To The Test

By Martha Bebinger, WBUR November 27, 2018 KFF Health News Original

A woman had twins in a hospital south of Boston, and for doctors aiming to reduce cesarean sections, the second baby’s tricky arrival tested the limits of teamwork.

Staggering Prices Slow Insurers’ Coverage Of CAR-T Cancer Therapy

By Michelle Andrews July 17, 2018 KFF Health News Original

Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.

Facebook Live: Vaping Unveiled

May 31, 2018 KFF Health News Original

Nicotine-loaded e-cig juices that spoof popular treats — marketed to help adults kick the smoking habit— instead may be luring youths into addiction. California Healthline’s Facebook Live peeled back the curtains on this wolf in sheep’s clothing.

At Meeting Of Key Medicare Advisers, Attendees Ponder: What Can Medicare Learn From Major League Baseball?

March 8, 2019 Morning Briefing

Members of the Medicare Payment Advisory Commission met to discuss ways to curb high drug prices in Medicare Part B, the portion of Medicare that pays for drugs administered in a doctor’s office. The commission, which is made up of economists, doctors, and various other health policy experts, is not well-known outside of D.C., but their suggestions carry a lot of weight with lawmakers who are looking to improve Medicare.

Sprained Your Ankle? The Cost Of A Brace Could Sprain Your Wallet.

By Michelle Andrews May 3, 2018 KFF Health News Original

Your health insurance might not cover items such as wheelchairs, walkers, crutches and braces, or you may have to deal with a supplier that has a contract with your insurer.

Hospitals Score Victory As Judge Rules That Administration’s Cuts To 340B Program Overstepped Authority

January 2, 2019 Morning Briefing

The hospital groups fighting the Trump administration’s change to the 340B drug discount program said that the cuts impeded their ability to provide care for low-income patients. In his opinion, Judge Rudolph Contreras said that, while the HHS secretary does have the authority to make “adjustments” to the program, “he cannot fundamentally rework the statutory scheme.”

Taken For A Ride: After ATV Crash, Doctor Gets $56,603 Bill For Air Ambulance Trip

By Alison Kodjak, NPR News September 26, 2018 KFF Health News Original

After an accident in an all-terrain vehicle crushed a doctor’s left arm, he was whisked by air ambulance to the closest trauma center for specialized care. Soon he was fighting over the $56,603 bill.

If High Court Reverses Roe V. Wade, 22 States Poised To Ban Abortion

By Julie Rovner July 10, 2018 KFF Health News Original

As with current abortion policies, a woman’s access to the procedure would continue to be determined by where she lives.

State Pay Cut For Dental Hygienists Who Serve The Poor Was Illegal, Court Finds

By Ana B. Ibarra March 2, 2018 KFF Health News Original

California officials should have obtained federal approval before they cut reimbursement rates for dental hygienists who serve frail Californians living in nursing homes and board-and-care facilities, a judge has ruled.

Outrageous Or Overblown? HHS Announces Another Round Of ACA Navigator Funding Cuts

By Phil Galewitz July 12, 2018 KFF Health News Original

Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.

With Some Republican Support, Virginia Edges Closer To Medicaid Expansion

By Megan Pauly, WCVE March 16, 2018 KFF Health News Original

More than a dozen Republicans in the Virginia House of Delegates voted to expand Medicaid, and at least one state senator may be leaning in favor of expansion. It will be the hot topic as legislators are called back to Richmond to hash out a budget in the special session starting April 11.

Bristol-Meyers Announces $74B Merger With Celgene In Deal Primed To Have Sweeping Implications For Drug Industry

January 4, 2019 Morning Briefing

In the first major pharmaceutical deal of 2019, Bristol-Myers Squibb says it will buy Celgene, a maker of cancer-fighting drugs, in a merger valued at $74 billion. According to Stat, Bristol-Myers has been under pressure to set a new course since August 2016, when a big study of its cancer immunotherapy, Opdivo, failed to show a benefit in previously untreated patients with non-small cell lung cancer. Analysts look at what the deal means to the industry at large.

Podcast: KHN’s ‘What The Health?’ Health Law Fix Misses The Spending Bill Train

March 23, 2018 KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

Scrutinizing Medicare Coverage For Physical, Occupational And Speech Therapy

By Judith Graham March 29, 2018 KFF Health News Original

Treatment has been terminated for some seniors because therapists told them they weren’t making enough progress or that they had reached their annual limit. We examine the treatment benefits and the barriers under Medicare’s coverage rules for therapy.

Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change

By Sarah Jane Tribble and Liz Szabo May 11, 2018 KFF Health News Original

President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.

Impact Of Drug Prices In TV Ads Mitigated If Consumers Think They Could Be Eligible For Free Treatment

January 24, 2019 Morning Briefing

A new study looked at the effectiveness of the Trump administration’s proposal to require drugmakers to state prices in TV commercials. While putting the costs in did affect consumers, the impact was muted if the ad’s language suggests that some people could get the treatment for free. In other pharmaceutical news: foreign drug pricing, the controversial 340B program, negotiating powers for Medicaid, and more.

Poison Ivy, A ‘Familiar Stranger’ That Could Ruin Your Summer

By Blake Farmer, Nashville Public Radio June 11, 2018 KFF Health News Original

Spotting poison ivy is tricky because it can come in several forms. And bad rashes may need to be treated by a doctor. Warning: This story might make you itch.

Drug Giant Eli Lilly To Purchase Tiny Startup In $8B Deal To Get Access To Company’s Cancer Treatments

January 8, 2019 Morning Briefing

The purchase could be very lucrative for Eli Lilly. Loxo Oncology’s drug Vitrakvi was approved by the FDA recently based on evidence that it can shrink tumors in 75 percent of patients whose cancer tests positive for a particular kind of genetic mutation.

California Takes On Health Giant Over High Costs

By Chad Terhune and Ana B. Ibarra April 1, 2018 KFF Health News Original

The lawsuit is a bold move against Northern California’s dominant hospital chain, whose prices have drawn complaints for years. It has disputed such allegations in the past.

Filter Results

More From KFF Health News